Johnson & Johnson plans to break up into two companies, splitting off the $15-billion-a-year division that sells Band-Aid bandages, Tylenol medicines and Johnson’s Baby Powder in a shift indicating just how much healthcare has changed since the company helped pioneer the industry.

The world’s largest health-products company by sales will separate its high-margin but risky prescription-drugs and medical-devices business from its storied but slower-growing consumer group, creating two publicly traded companies.

This post first appeared on wsj.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Colorado man was killed by venom from his pet Gila monster, autopsy finds

GOLDEN, Colo. — A Colorado man who was placed on life support…

Jacksonville Jaguars fire head coach Urban Meyer after 13 games, missteps

JACKSONVILLE, Fla. — Urban Meyer’s tumultuous NFL tenure ended after just 13…

RFK Jr. is teasing an independent 2024 run. His supporters show why.

WARREN, Mich. — Robert F. Kennedy Jr. once again teased a potential…

Party and protest mix as LGBTQ+ pride parades kick off from New York to San Francisco

NEW YORK — Celebrations mingled with displays of resistance Sunday as LGBTQ+…